62 related articles for article (PubMed ID: 34491768)
1. Hybrid Cyclic-Linear Cell-Penetrating Peptides Containing Alternative Positively Charged and Hydrophobic Residues as Molecular Transporters.
Khayyatnejad Shoushtari S; Zoghebi K; Sajid MI; Tiwari RK; Parang K
Mol Pharm; 2021 Oct; 18(10):3909-3919. PubMed ID: 34491768
[TBL] [Abstract][Full Text] [Related]
2. Peptide amphiphile containing arginine and fatty acyl chains as molecular transporters.
Nasrolahi Shirazi A; Oh D; Tiwari RK; Sullivan B; Gupta A; Bothun GD; Parang K
Mol Pharm; 2013 Dec; 10(12):4717-27. PubMed ID: 24215132
[TBL] [Abstract][Full Text] [Related]
3. Chiral Cyclobutane-Containing Cell-Penetrating Peptides as Selective Vectors for Anti-
Illa O; Olivares JA; Gaztelumendi N; Martínez-Castro L; Ospina J; Abengozar MÁ; Sciortino G; Maréchal JD; Nogués C; Royo M; Rivas L; Ortuño RM
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053805
[TBL] [Abstract][Full Text] [Related]
4. Cyclic peptides containing tryptophan and arginine as Src kinase inhibitors.
Nasrolahi Shirazi A; Tiwari RK; Brown A; Mandal D; Sun G; Parang K
Bioorg Med Chem Lett; 2013 Jun; 23(11):3230-4. PubMed ID: 23602444
[TBL] [Abstract][Full Text] [Related]
5. Taurine Boosts Cellular Uptake of Small D-Peptides for Enzyme-Instructed Intracellular Molecular Self-Assembly.
Zhou J; Du X; Li J; Yamagata N; Xu B
J Am Chem Soc; 2015 Aug; 137(32):10040-3. PubMed ID: 26235707
[TBL] [Abstract][Full Text] [Related]
6. Achieving enhanced cell penetration of short conformationally constrained peptides through amphiphilicity tuning.
Tian Y; Zeng X; Li J; Jiang Y; Zhao H; Wang D; Huang X; Li Z
Chem Sci; 2017 Nov; 8(11):7576-7581. PubMed ID: 29568420
[TBL] [Abstract][Full Text] [Related]
7. Design of aromatic-containing cell-penetrating peptide mimics with structurally modified π electronics.
deRonde BM; Birke A; Tew GN
Chemistry; 2015 Feb; 21(7):3013-9. PubMed ID: 25537501
[TBL] [Abstract][Full Text] [Related]
8. Reinventing Cell Penetrating Peptides Using Glycosylated Methionine Sulfonium Ion Sequences.
Kramer JR; Schmidt NW; Mayle KM; Kamei DT; Wong GC; Deming TJ
ACS Cent Sci; 2015 May; 1(2):83-8. PubMed ID: 27162954
[TBL] [Abstract][Full Text] [Related]
9. A Quantitative Method to Distinguish Cytosolic from Endosome-Trapped Cell-Penetrating Peptides.
Illien F; Bánóczi Z; Sagan S
Chembiochem; 2024 Apr; ():e202400198. PubMed ID: 38589287
[TBL] [Abstract][Full Text] [Related]
10.
Afonin S; Koniev S; Préau L; Takamiya M; Strizhak AV; Babii O; Hrebonkin A; Pivovarenko VG; Dathe M; le Noble F; Rastegar S; Strähle U; Ulrich AS; Komarov IV
Front Chem; 2021; 9():688446. PubMed ID: 34262894
[TBL] [Abstract][Full Text] [Related]
11. To What Extent Do Fluorophores Bias the Biological Activity of Peptides? A Practical Approach Using Membrane-Active Peptides as Models.
Cavaco M; Pérez-Peinado C; Valle J; Silva RDM; Correia JDG; Andreu D; Castanho MARB; Neves V
Front Bioeng Biotechnol; 2020; 8():552035. PubMed ID: 33015016
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of herpes simplex keratitis following vaccination for COVID-19.
Richardson-May J; Rothwell A; Rashid M
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34493563
[TBL] [Abstract][Full Text] [Related]
13. Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study.
Taramasso L; De Vito A; Ricci ED; Orofino G; Squillace N; Menzaghi B; Molteni C; Gulminetti R; De Socio GV; Pellicanò GF; Sarchi E; Celesia BM; Calza L; Rusconi S; Valsecchi L; Martinelli CV; Cascio A; Maggi P; Vichi F; Angioni G; Guadagnino G; Cenderello G; Dentone C; Bandera A; Falasca K; Bonfanti P; Di Biagio A; Madeddu G;
AIDS Patient Care STDS; 2021 Sep; 35(9):342-353. PubMed ID: 34524918
[TBL] [Abstract][Full Text] [Related]
14. Anti-Inflammatory Nanotherapeutics by Targeting Matrix Metalloproteinases for Immunotherapy of Spinal Cord Injury.
Shen K; Sun G; Chan L; He L; Li X; Yang S; Wang B; Zhang H; Huang J; Chang M; Li Z; Chen T
Small; 2021 Oct; 17(41):e2102102. PubMed ID: 34510724
[TBL] [Abstract][Full Text] [Related]
15. Protocol for active safety monitoring of a cohort of patients using a dolutegravir-based antiretroviral regimen in Mozambique.
Mussá M; Gaspar I; Namburete L; Sitoie TV; Couto A; Paulino JM; Lemos A; Vilanculos S; Ogar CK; Namburete D; Seni ED; Hafner T; Stergachis A
BMJ Open; 2021 Sep; 11(9):e050671. PubMed ID: 34493520
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of pore formation in stearoyl-oleoyl-phosphatidylcholine vesicles by pH sensitive cell penetrating peptide GALA.
James HP; Jadhav S
Chem Phys Lipids; 2021 Nov; 241():105139. PubMed ID: 34560061
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and DNA interaction studies of Ru(II) cell penetrating peptide (CPP) bioconjugates.
Obitz D; Miller RG; Metzler-Nolte N
Dalton Trans; 2021 Oct; 50(39):13768-13777. PubMed ID: 34549219
[TBL] [Abstract][Full Text] [Related]
18. Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A.
Bippes CC; Kohler C; Garcia-Tirado E; Burri R; Frauenknecht T; Gerard MA; Salat M; Allenspach R; Agca C; Wu Z; Trost A; Bogner B; Meyer P; Scholl HPN; Reitsamer H; Flammer J; Neutzner A
Mol Ther; 2022 Feb; 30(2):855-867. PubMed ID: 34547467
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects, immunogenicity and cytotoxicity of a cell penetrating peptide-peptide nucleic acid conjugate against
Farahani NN; Kalani BS; Monavari SH; Mirkalantari S; Montazer F; Sholeh M; Javanmard Z; Irajian G
Iran J Microbiol; 2021 Jun; 13(3):360-371. PubMed ID: 34540175
[TBL] [Abstract][Full Text] [Related]
20. Design and application of hybrid cyclic-linear peptide-doxorubicin conjugates as a strategy to overcome doxorubicin resistance and toxicity.
Mozaffari S; Salehi D; Mahdipoor P; Beuttler R; Tiwari R; Aliabadi HM; Parang K
Eur J Med Chem; 2021 Dec; 226():113836. PubMed ID: 34537446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
